Bio-Rad Laboratories, Inc. (BIO) Analysts See $0.63 EPS; 0 Analysts Are Bullish Heartland Express, Inc. (HTLD) Last Week

August 2, 2017 - By Clifton Ray

Among 11 analysts covering Heartland Express (NASDAQ:HTLD), 0 have Buy rating, 4 Sell and 7 Hold. Therefore 0 are positive. Heartland Express had 19 analyst reports since July 30, 2015 according to SRatingsIntel. On Thursday, January 7 the stock rating was downgraded by RBC Capital Markets to “Underperform”. UBS upgraded Heartland Express, Inc. (NASDAQ:HTLD) on Monday, July 10 to “Hold” rating. The firm earned “Underweight” rating on Monday, October 5 by Barclays Capital. Stifel Nicolaus upgraded Heartland Express, Inc. (NASDAQ:HTLD) on Friday, February 10 to “Hold” rating. The rating was maintained by Barclays Capital with “Underweight” on Wednesday, April 6. The firm has “Underweight” rating given on Tuesday, January 12 by Barclays Capital. The stock has “Equal-Weight” rating by Stephens on Friday, October 21. The stock has “Underperform” rating by Wolfe Research on Wednesday, October 28. On Monday, May 9 the stock rating was downgraded by Wells Fargo to “Underperform”. Stifel Nicolaus downgraded Heartland Express, Inc. (NASDAQ:HTLD) on Friday, December 16 to “Hold” rating. See Heartland Express, Inc. (NASDAQ:HTLD) latest ratings:

10/07/2017 Broker: UBS Rating: Hold New Target: $22.0000 Upgrade
10/02/2017 Broker: Stifel Nicolaus Old Rating: Sell New Rating: Hold Old Target: $18 New Target: $19 Upgrade

Analysts expect Bio-Rad Laboratories, Inc. (NYSE:BIO) to report $0.63 EPS on August, 3 after the close.They anticipate $0.02 EPS change or 3.28% from last quarter’s $0.61 EPS. BIO’s profit would be $18.66M giving it 94.33 P/E if the $0.63 EPS is correct. After having $0.41 EPS previously, Bio-Rad Laboratories, Inc.’s analysts see 53.66% EPS growth. The stock increased 0.88% or $2.08 during the last trading session, reaching $237.71. About shares traded. Bio-Rad Laboratories, Inc. (NYSE:BIO) has risen 53.78% since August 2, 2016 and is uptrending. It has outperformed by 37.08% the S&P500.

Since February 8, 2017, it had 0 buys, and 1 sale for $1.91 million activity. Gordon Larry J. also sold $1.91 million worth of Heartland Express, Inc. (NASDAQ:HTLD) on Wednesday, February 8.

Investors sentiment increased to 1.34 in Q4 2016. Its up 0.54, from 0.8 in 2016Q3. It is positive, as 14 investors sold Heartland Express, Inc. shares while 39 reduced holdings. 22 funds opened positions while 49 raised stakes. 47.07 million shares or 1.42% more from 46.41 million shares in 2016Q3 were reported. Aperio Grp Ltd Llc owns 27,944 shares for 0% of their portfolio. Fmr Llc owns 589,880 shares or 0% of their US portfolio. Century Cos owns 0.2% invested in Heartland Express, Inc. (NASDAQ:HTLD) for 9.09 million shares. 12,023 are held by Capstone Asset Company. Cipher Cap Limited Partnership has invested 0.21% in Heartland Express, Inc. (NASDAQ:HTLD). Ngam Advsrs Ltd Partnership stated it has 19,899 shares. Bnp Paribas Arbitrage has 0% invested in Heartland Express, Inc. (NASDAQ:HTLD) for 10,194 shares. Voya Invest Mngmt Ltd Company holds 18,849 shares or 0% of its portfolio. 31,588 were accumulated by Texas Permanent School Fund. National Bank & Trust accumulated 25,710 shares. Secor Capital Limited Partnership reported 41,863 shares. State Common Retirement Fund has 0% invested in Heartland Express, Inc. (NASDAQ:HTLD) for 65,000 shares. Pacad Invest Limited stated it has 0.01% of its portfolio in Heartland Express, Inc. (NASDAQ:HTLD). Thrivent Fin For Lutherans, a Minnesota-based fund reported 23,348 shares. Tortoise Ltd Liability Corporation reported 0% of its portfolio in Heartland Express, Inc. (NASDAQ:HTLD).

The stock increased 0.05% or $0.01 during the last trading session, reaching $21.14. About shares traded. Heartland Express, Inc. (NASDAQ:HTLD) has risen 9.15% since August 2, 2016 and is uptrending. It has underperformed by 7.55% the S&P500.

Heartland Express, Inc. is a holding company. The company has market cap of $1.76 billion. The Firm is a short-to-medium haul truckload carrier. It has a 31.43 P/E ratio. The Firm focuses primarily on short- to medium-haul, asset dry van truckload services in regional markets near its terminals.

Since March 2, 2017, it had 1 buy, and 6 insider sales for $2.95 million activity. Shares for $58,840 were sold by Crowley Michael on Tuesday, March 7. Another trade for 3,500 shares valued at $770,590 was sold by GOETZ JOHN. 2,113 shares were sold by Magni Giovanni, worth $465,346 on Thursday, May 18. Shares for $109,792 were bought by HINCKLEY GREGORY K on Friday, May 26. The insider Hall Shannon sold 900 shares worth $200,387.

Bio-Rad Laboratories, Inc. is a maker and distributor of its life science research and clinical diagnostics products. The company has market cap of $7.04 billion. The Firm operates through two divisions: Life Science and Clinical Diagnostics. It has a 250.72 P/E ratio. It makes and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.